PharmaCyte Biotech, Inc. (PMCB) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-04-02 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-12-05 | 8-K | Listing Notice | SEC |
| 2025-10-31 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-09-05 | 8-K | Material Agreement, Acquisition or Disposition, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-18 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-24 | 8-K | Shareholder Vote Results | SEC |
| 2025-02-26 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-05-23 | 8-K | Material Agreement, Acquisition or Disposition, Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-01 | 8-K | Shareholder Vote Results | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.